S&P 500 Adds 0.2% as Tech Offsets Quiet Bond Tape

We expect the S&P 500 to close up roughly 0.2% on Friday, November 13, 2026, while the Nasdaq 100 gains about 0.35% as steady enterprise software bookings prevent a deeper November pullback. Major equity benchmarks have spent three weeks trapped in a range, sitting 1.03% below their 50-day moving average but still 3.48% above their 200-day baseline. Without aggressive selling in corporate bonds or fresh negative economic data, institutional capital tends to drift back toward high-cash-flow corporate leaders into the weekend.

Enterprise software remains the primary pillar holding up large-cap valuations. Microsoft (MSFT) continues to expand its cloud infrastructure revenue at an annual clip above 20%, driven by Fortune 500 clients renewing automated productivity licenses. IBM (IBM) provides a similar floor for corporate IT sentiment, with hybrid cloud software subscriptions generating over 55% of its quarterly gross profit. When corporations manage tight budgets, they cut experimental hiring rather than core database infrastructure. That dynamic should lift Microsoft (MSFT) by about 0.5% and IBM (IBM) by 0.3% on Friday, November 13, 2026, protecting the broader market from broader industrial softness.

Semiconductor hardware shows a similar split between specialized networking gear and commodity components. Broadcom (AVGO) commands steady pricing because its high-bandwidth switching chips are required for modern data center expansion. Rather than chasing unproven hardware startups, major cloud operators are concentrating capital on proven network architects, which should help Broadcom (AVGO) add 1.0% on Friday, November 13, 2026. Conversely, Applied Materials (AMAT) and smaller hardware suppliers face longer factory deployment cycles, keeping equipment stocks relatively flat as global chipmaker construction plans pause for annual budget reviews.

Healthcare offers the day's main defensive anchor outside technology. Eli Lilly (LLY) continues to see commercial sales for its metabolic medications grow faster than retail pharmacy inventory, giving the company an earnings profile largely independent of the economic cycle. Investors looking for safety outside of cash deposits have consistently bid pharmaceutical leaders with visible multi-year prescription growth. We look for Eli Lilly (LLY) to rise roughly 0.6% on Friday, November 13, 2026, helping the healthcare sector deliver a 56% probability of a green session.

Energy remains the clear drag on index performance. Marathon Oil (MRO) reports after Friday's close, but softening benchmark crude prices and elevated West Texas pipeline supplies have already clipped quarterly drilling margins. Exxon Mobil (XOM) faces similar valuation pressure as prompt-month fuel delivery prices slide, leading us to forecast a 0.45% decline for crude oil and a flat-to-down session for exploration shares.

What would break this forecast is an unexpected spike in the 10-year Treasury yield back toward 4.55%, or an unexpected drop in preliminary Michigan consumer sentiment below 68.0 at 10:00 AM ET. A sudden jump in borrowing costs would instantly pressure high-multiple software stocks, turning a gentle 0.2% drift into a 0.8% broad index drop.